The Globe and Mail reports in its Thursday, April 3, edition that Scotia Capital analyst Konark Gupta believes that tariff uncertainty is more of a threat to the recovery of Canadian transportation stocks than the tariffs themselves. The Globe's David Leeder writes in the Eye On Equities column that Mr. Gupta reduced his first quarter and full-year estimates by 2 to 3 per cent and lowered valuation multiples due to macroeconomic risks, resulting in a 9-per-cent drop in his target prices for the stocks he covers. Mr. Gupta has reaffirmed his "sector perform" recommendation for Andlauer Healthcare Group. Mr. Gupta gave his share target a $1.50 trim to $43. Analysts on average target the shares at $49.08. Mr. Gupta says in a note: "Andlaur is trading at 9.5 times on our 2025E, slightly above its 9.1 times forward valuation at the time of IPO. We think U.S. TL [truckload] business recovery and potential M&A hold the key to multiple expansion. However, we are expecting U.S. TL to further weaken this year, partially offsetting mid-single digit organic growth in the Canadian business. Andlaur is also well-positioned to make more acquisitions although deal timing and magnitude are difficult to predict."